Barclays
SLS icon

Barclays’s SELLAS Life Sciences SLS Stock Holding History

Barclays’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.6M Buy
1,185,000
+383,400
+48% +$4.8M ﹤0.01% 1420
2026
Q2 		$11.8M Buy
+801,600
New +$5.53M ﹤0.01% 1403
2026
Q1 		– Sell
-200,000
Closed -$754K – 5395
2025
Q4 		$754K Buy
+200,000
New +$389K ﹤0.01% 3620

Other funds holding SLS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Barclays's SLS Position: Q3 2026 in Review

Barclays increased its SELLAS Life Sciences (SLS) stake by 148% in Q3 2026, buying an estimated $665K and bringing the position to 88,866 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

Barclays first reported a position in SLS in Q1 2017 and has held it in 10 quarters since. The position peaked at $1.93M in Q4 2025. 112 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Barclays held 88,866 shares of SELLAS Life Sciences worth $1.09M as of Q3 2026.
  • Barclays bought 53,083 SELLAS Life Sciences shares in Q3 2026, an estimated $665K.
  • SELLAS Life Sciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2985 holding.
  • Barclays first reported a position in SELLAS Life Sciences in Q1 2017 and has held it in 10 quarters since.
  • Barclays's SELLAS Life Sciences position peaked at $1.93M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.